Last reviewed · How we verify
NCT04262453: SAOS-K
Obstructive Sleep Apnea Syndrome In Patients Treated For Cancer Of The Upper Aerodigestive Tract
trial in Upper Aerodigestive Tract Neoplasms in 142 participants. Completed in 20 September 2023.
20 September 2023
Quick facts
| Lead sponsor | Centre Hospitalier Sud Francilien |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 142 |
| Start date | 21 January 2019 |
| Primary completion | 20 September 2023 |
| Estimated completion | 20 September 2023 |
| Sites | 1 location across France |
Conditions studied
- Upper Aerodigestive Tract Neoplasms — all drugs for Upper Aerodigestive Tract Neoplasms →
- Obstructive Sleep Apnea-hypopnea Syndrome — all drugs for Obstructive Sleep Apnea-hypopnea Syndrome →
Sponsor
Centre Hospitalier Sud Francilien
Who can join
18 and older, any sex, with Upper Aerodigestive Tract Neoplasms or Obstructive Sleep Apnea-hypopnea Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective open-label, non-randomized, monocentric, cohort study, to assess the prevalence and severity of sleep apnea syndrome in patients treated for cancer of the upper aerodigestive tract. The patient follows a usual course of care including, at the end of the treatment of his cancer of the upper aerodigestive tract, screening for obstructive sleep apnea syndrome at 3 months and 6 months (Epworth score and ventilatory polygraphy)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04262453
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre Hospitalier Sud Francilien trials
Trials by the same sponsor.
- NCT07495709 — Reactions to Oro-facial Solicitations : a Predictor of Eating Difficulties for Premature Babies of 36 Weeks Gestation Ad · not yet recruiting
- NCT07430293 — Hybrid Closed-Loop Insulin Delivery After Pancreatectomy · NA · not yet recruiting
- NCT07414186 — Study of Pre Hospital Management of Polytrauma Patients by Medical Teams From a Department in the Parisian Region · not yet recruiting
- NCT07144059 — Impact of Non-medicalized ECG Practices Initiated by SAMU in Dispatch Strategies · not yet recruiting
- NCT07329192 — Study on How Parents' Anticipated Choice of a Doctor at the Maternity Hospital Influences the Newborn's First Post-disch · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04262453 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Sud Francilien
- Last refreshed: 7 November 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04262453.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing